IBDEI082 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3211,1,3,0)
 ;;=3^Atherosclerosis,Unspec
 ;;^UTILITY(U,$J,358.3,3211,1,4,0)
 ;;=4^I70.90
 ;;^UTILITY(U,$J,358.3,3211,2)
 ;;=^5007784
 ;;^UTILITY(U,$J,358.3,3212,0)
 ;;=I25.10^^28^249^18
 ;;^UTILITY(U,$J,358.3,3212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3212,1,3,0)
 ;;=3^Athscl Hrt Disease Native Coronary Artery w/o Angina Pectoris
 ;;^UTILITY(U,$J,358.3,3212,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,3212,2)
 ;;=^5007107
 ;;^UTILITY(U,$J,358.3,3213,0)
 ;;=I48.91^^28^249^19
 ;;^UTILITY(U,$J,358.3,3213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3213,1,3,0)
 ;;=3^Atrial Fibrillation,Unspec
 ;;^UTILITY(U,$J,358.3,3213,1,4,0)
 ;;=4^I48.91
 ;;^UTILITY(U,$J,358.3,3213,2)
 ;;=^5007229
 ;;^UTILITY(U,$J,358.3,3214,0)
 ;;=Z95.1^^28^249^21
 ;;^UTILITY(U,$J,358.3,3214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3214,1,3,0)
 ;;=3^Bypass Graft,Aortocoronary
 ;;^UTILITY(U,$J,358.3,3214,1,4,0)
 ;;=4^Z95.1
 ;;^UTILITY(U,$J,358.3,3214,2)
 ;;=^5063669
 ;;^UTILITY(U,$J,358.3,3215,0)
 ;;=I78.9^^28^249^22
 ;;^UTILITY(U,$J,358.3,3215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3215,1,3,0)
 ;;=3^Capillary Disease,Unspec
 ;;^UTILITY(U,$J,358.3,3215,1,4,0)
 ;;=4^I78.9
 ;;^UTILITY(U,$J,358.3,3215,2)
 ;;=^5007816
 ;;^UTILITY(U,$J,358.3,3216,0)
 ;;=I51.7^^28^249^23
 ;;^UTILITY(U,$J,358.3,3216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3216,1,3,0)
 ;;=3^Cardiomegaly
 ;;^UTILITY(U,$J,358.3,3216,1,4,0)
 ;;=4^I51.7
 ;;^UTILITY(U,$J,358.3,3216,2)
 ;;=^5007257
 ;;^UTILITY(U,$J,358.3,3217,0)
 ;;=I42.1^^28^249^24
 ;;^UTILITY(U,$J,358.3,3217,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3217,1,3,0)
 ;;=3^Cardiomyopathy,Obstructive Hypertrophic
 ;;^UTILITY(U,$J,358.3,3217,1,4,0)
 ;;=4^I42.1
 ;;^UTILITY(U,$J,358.3,3217,2)
 ;;=^340520
 ;;^UTILITY(U,$J,358.3,3218,0)
 ;;=I42.2^^28^249^25
 ;;^UTILITY(U,$J,358.3,3218,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3218,1,3,0)
 ;;=3^Cardiomyopathy,Other Hypertrophic
 ;;^UTILITY(U,$J,358.3,3218,1,4,0)
 ;;=4^I42.2
 ;;^UTILITY(U,$J,358.3,3218,2)
 ;;=^340521
 ;;^UTILITY(U,$J,358.3,3219,0)
 ;;=Z13.6^^28^249^26
 ;;^UTILITY(U,$J,358.3,3219,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3219,1,3,0)
 ;;=3^Cardiovascular Disorder Screening
 ;;^UTILITY(U,$J,358.3,3219,1,4,0)
 ;;=4^Z13.6
 ;;^UTILITY(U,$J,358.3,3219,2)
 ;;=^5062707
 ;;^UTILITY(U,$J,358.3,3220,0)
 ;;=G45.1^^28^249^27
 ;;^UTILITY(U,$J,358.3,3220,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3220,1,3,0)
 ;;=3^Carotid Artery Syndrome
 ;;^UTILITY(U,$J,358.3,3220,1,4,0)
 ;;=4^G45.1
 ;;^UTILITY(U,$J,358.3,3220,2)
 ;;=^5003956
 ;;^UTILITY(U,$J,358.3,3221,0)
 ;;=I65.29^^28^249^28
 ;;^UTILITY(U,$J,358.3,3221,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3221,1,3,0)
 ;;=3^Carotid Artery,Occlusion & Stenosis,Unspec
 ;;^UTILITY(U,$J,358.3,3221,1,4,0)
 ;;=4^I65.29
 ;;^UTILITY(U,$J,358.3,3221,2)
 ;;=^5007363
 ;;^UTILITY(U,$J,358.3,3222,0)
 ;;=R09.89^^28^249^29
 ;;^UTILITY(U,$J,358.3,3222,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3222,1,3,0)
 ;;=3^Carotid Bruit
 ;;^UTILITY(U,$J,358.3,3222,1,4,0)
 ;;=4^R09.89
 ;;^UTILITY(U,$J,358.3,3222,2)
 ;;=^5019204
 ;;^UTILITY(U,$J,358.3,3223,0)
 ;;=I63.239^^28^249^30
 ;;^UTILITY(U,$J,358.3,3223,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3223,1,3,0)
 ;;=3^Cerebral Infarction d/t Occlusion/Stenosis Carotid Arteries
 ;;^UTILITY(U,$J,358.3,3223,1,4,0)
 ;;=4^I63.239
 ;;^UTILITY(U,$J,358.3,3223,2)
 ;;=^5133567
 ;;^UTILITY(U,$J,358.3,3224,0)
 ;;=I63.20^^28^249^31
 ;;^UTILITY(U,$J,358.3,3224,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3224,1,3,0)
 ;;=3^Cerebral Infarction d/t Occlusion/Stenosis Percerebral Arteries
